Detailed analysis of cytolytic T lymphocytes (CTL)1 at the molecular level has been hampered by the cellular heterogeneity intrinsic to most model systems studied. The development of cloned lines (1, 2) of CTL facilitates both biochemical (3) and genetic (this report) analyses of function.CTL have been characterized by a distinctive cell surface antigenic profile that includes Thy-1, Lyt-2, and Lyt-3 (4). Several recent studies using alloantisera indicate that antibodies reactive with either Lyt-2 or Lyt-3, or with the product of a closelinked locus, are able to block CTL activity in the absence of complement (5, 6). Monoclonal antibodies directed against either Lyt-2 (7, 8) or Lyt-3 (J. A. Ledbetter and L. A. Herzenberg, personal communication) also have been found to block CTL activity in the absence of complement. These data imply a role for Lyt-2 and Lyt-3 in cytolysis, but they cannot formally exclude that a molecule required for cytolytic activity merely is located near Lyt-2 and Lyt-3 on the cell surface. Antibody to Thy-1 does not block CTL activity in the absence of complement (7-9).To investigate the role of Lyt-2 and Thy-1 in cytolysis from an independent approach, we have generated, and analyzed the phenotypes of, variants of an especially lytic cloned CTL line (designated L3) which specifically lack either Lyt-2 or Thy-1. An analysis of these variants indicates that neither Lyt-2 nor Lyt-3 is responsible for the lethal hit, but suggests that Lyt-2 and/or Lyt-3 are required for an antigen receptor functional in cytolysis. The data also suggest that the expression of Lyt-3 on the cell surface is not independent of the expression of Lyt-2. Finally the data indicate that Thy-1 plays no role in cytolysis.